Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (ATYR)
NASDAQ:ATYR
aTyr Pharma (ATYR) Ownership - Who Owns aTyr Pharma?
1,784 Followers
aTyr Pharma (ATYR) Ownership Overview
2.79% Insiders
27.85% Mutual Funds
21.73% Other Institutional Investors
47.63% Public Companies and Individual Investors
The ownership structure of aTyr Pharma (ATYR) stock is a mix of institutional, retail and individual investors. Approximately 49.58% of the company’s stock is owned by Institutional Investors, 2.79% is owned by Insiders and 47.63% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 03, 2024 | Sanjay Shukla President & Ceo,director | Bought | $36000 |
| Jun 03, 2024 | Timothy Coughlin Director | Bought | $87500 |
| Dec 12, 2023 | Sanjay Shukla President & Ceo,director | Bought | $17550 |
| Nov 13, 2023 | Sanjay Shukla President & Ceo,director | Bought | $16678 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Bought | $3278494 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,049,000 | Institution | 14.56% | 15,676,440 | |
| 3,499,791 | Institution | 5.07% | 5,459,674 | |
| 2,536,244 | Institution | 3.68% | 3,956,541 | |
| 2,536,244 | Institution | 3.68% | 3,956,541 | |
| 2,258,063 | Institution | 3.27% | 3,522,578 | |
| 1,681,279 | Institution | 2.44% | 2,622,795 | |
| 561,937 | Institution | 0.81% | 876,622 | |
| 179,770 | Institution | 0.26% | 280,441 | |
| 148,316 | Institution | 0.21% | 231,373 | |
| 62,500 | Institution | 0.09% | 97,500 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,049,000 | Institution | 14.56% | 15,676,440 | |
| 3,499,791 | Institution | 5.07% | 5,459,674 | |
| 2,536,244 | Institution | 3.68% | 3,956,541 | |
| 2,258,063 | Institution | 3.27% | 3,522,578 | |
| 561,937 | Institution | 0.81% | 876,622 | |
| 179,770 | Institution | 0.26% | 280,441 | |
| 62,500 | Institution | 0.09% | 97,500 | |
| 38,420 | Institution | 0.06% | 59,935 | |
| 26,689 | Institution | 0.04% | 41,635 | |
| 8,468 | Institution | 0.01% | 13,210 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,748,835 | Institution | 2.53% | 3,025,485 | |
| 787,409 | Institution | 1.14% | 1,362,218 | |
| 148,316 | Institution | 0.21% | 231,373 | |
| 60,487 | Institution | 0.09% | 93,150 | |
| 550 | Institution | <0.01% | 847 |
FAQ
Who Owns aTyr Pharma (ATYR)?
According to the latest TipRanks data, approximately 21.73% of the company's stock is held by institutional investors, 2.79% is held by insiders, and 47.63% is held by retail investors.
What percentage of aTyr Pharma (ATYR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 21.73% of aTyr Pharma (ATYR) stock is held by institutional investors.
What percentage of aTyr Pharma (ATYR) stock is held by retail investors?
According to the latest TipRanks data, approximately 47.63% of aTyr Pharma (ATYR) stock is held by retail investors.
Who owns the most shares of aTyr Pharma (ATYR)?
Federated Hermes Equity Funds owns the most shares of aTyr Pharma (ATYR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.